0001140361-22-009254.txt : 20220311
0001140361-22-009254.hdr.sgml : 20220311
20220311210616
ACCESSION NUMBER: 0001140361-22-009254
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220311
FILED AS OF DATE: 20220311
DATE AS OF CHANGE: 20220311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Apelian David
CENTRAL INDEX KEY: 0001546842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 22734908
MAIL ADDRESS:
STREET 1: C/O ACHILLION PHARMACEUTICALS, INC
STREET 2: 300 GEORGE STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
form4.xml
FORM 4
X0306
4
2022-03-11
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001546842
Apelian David
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
true
Common Stock
2022-03-11
4
A
0
6000
0
A
16000
D
Stock Option (Right to Buy)
5.1
2022-03-11
4
A
0
12000
0
A
2032-03-10
Common Stock
12000
12000
D
Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022.
The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date.
/s/ Sriram Ryali, Attorney-in-Fact
2022-03-11